Home > ResourceBlog > Article

« All ResourceBlog Articles



Friday, 25th March 2011

Thomson Reuters Announces CI Tool for Biologic Drugs Research

By Africa S. Hands

From the press release:

The Newport Biologics Module is a vital addition to the Thomson Reuters Newport Premium™ solution and will allow generic drug companies, biotech firms or manufacturers of active pharmaceutical ingredients (API), to assess their own opportunities to enter the biosimilars market or to spot potential competitive activity.

Full story >>


Africa S. Hands is an independent librarian with a focus on helping professionals understand and utilise social media and search engines through one-on-one tutorials and small group workshops. Africa tweets (@africahands) on resources of interest to information and higher education professionals.

More articles by Africa S. Hands »

« All ResourceBlog Articles



Article Categories

All Article Categories »


All Archives »